Novocure Operating Income vs Total Operating Expenses Analysis

NVCR Stock

USD 21.51 0.66 2.98%

Novocure financial indicator trend analysis is infinitely more than just investigating Novocure recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Novocure is a good investment. Please check the relationship between Novocure Operating Income and its Total Operating Expenses accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novocure. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.

Operating Income vs Total Operating Expenses

Operating Income vs Total Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Novocure Operating Income account and Total Operating Expenses. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Novocure's Operating Income and Total Operating Expenses is -0.51. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Total Operating Expenses in the same time period over historical financial statements of Novocure, assuming nothing else is changed. The correlation between historical values of Novocure's Operating Income and Total Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of Novocure are associated (or correlated) with its Total Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Operating Expenses has no effect on the direction of Operating Income i.e., Novocure's Operating Income and Total Operating Expenses go up and down completely randomly.

Correlation Coefficient

-0.51

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Operating Income

Operating Income is the amount of profit realized from Novocure operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Novocure is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most indicators from Novocure's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Novocure current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novocure. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.As of 05/17/2024, Selling General Administrative is likely to drop to about 87.6 M. In addition to that, Tax Provision is likely to drop to about 9.1 M

	2021	2022	2023	2024 (projected)
Interest Expense	3.4M	3.3M	3.3M	3.2M
Depreciation And Amortization	10.3M	10.6M	11.0M	7.8M

Interest Expense Depreciation And Amortization

Novocure fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross
Total Assets		0.93	-0.45	0.89	0.93	0.65	0.95	0.8	0.91	-0.77	0.88	0.51	0.82	0.91	0.93	0.93	1.0	0.91	0.71	0.99	0.93	0.78	0.61	0.94	0.92	0.64
Short Long Term Debt Total	0.93		-0.54	0.98	0.82	0.62	0.83	0.94	0.98	-0.88	0.98	0.44	0.95	0.99	0.99	1.0	0.92	0.85	0.74	0.92	1.0	0.78	0.57	0.91	1.0	0.83
Other Current Liab	-0.45	-0.54		-0.55	-0.39	0.15	-0.44	-0.62	-0.52	0.35	-0.62	-0.25	-0.61	-0.52	-0.5	-0.54	-0.47	-0.26	-0.21	-0.47	-0.53	-0.16	0.22	-0.35	-0.54	-0.53
Total Current Liabilities	0.89	0.98	-0.55		0.76	0.63	0.79	0.97	0.96	-0.93	0.99	0.41	0.98	0.99	0.98	0.98	0.87	0.83	0.73	0.87	0.98	0.81	0.54	0.91	0.99	0.89
Total Stockholder Equity	0.93	0.82	-0.39	0.76		0.58	0.97	0.68	0.78	-0.57	0.77	0.58	0.7	0.82	0.84	0.82	0.95	0.83	0.52	0.92	0.82	0.59	0.56	0.81	0.81	0.5
Other Liab	0.65	0.62	0.15	0.63	0.58		0.54	0.49	0.59	-0.7	0.55	0.4	0.51	0.65	0.67	0.63	0.61	0.83	0.66	0.59	0.64	0.75	0.57	0.75	0.64	0.4
Net Tangible Assets	0.95	0.83	-0.44	0.79	0.97	0.54		0.74	0.78	-0.63	0.8	0.64	0.76	0.84	0.85	0.83	0.96	0.79	0.54	0.92	0.83	0.65	0.61	0.85	0.83	0.59
Property Plant And Equipment Net	0.8	0.94	-0.62	0.97	0.68	0.49	0.74		0.91	-0.9	0.98	0.39	1.0	0.95	0.94	0.93	0.79	0.7	0.64	0.78	0.94	0.75	0.5	0.84	0.95	0.96
Net Debt	0.91	0.98	-0.52	0.96	0.78	0.59	0.78	0.91		-0.89	0.95	0.25	0.92	0.95	0.96	0.98	0.9	0.84	0.72	0.93	0.98	0.81	0.55	0.91	0.98	0.79
Retained Earnings	-0.77	-0.88	0.35	-0.93	-0.57	-0.7	-0.63	-0.9	-0.89		-0.89	-0.24	-0.91	-0.88	-0.88	-0.88	-0.73	-0.78	-0.71	-0.75	-0.88	-0.93	-0.56	-0.92	-0.89	-0.88
Accounts Payable	0.88	0.98	-0.62	0.99	0.77	0.55	0.8	0.98	0.95	-0.89		0.42	0.99	0.98	0.98	0.98	0.87	0.79	0.68	0.87	0.98	0.76	0.52	0.88	0.99	0.9
Cash	0.51	0.44	-0.25	0.41	0.58	0.4	0.64	0.39	0.25	-0.24	0.42		0.41	0.5	0.49	0.43	0.52	0.43	0.39	0.39	0.44	0.22	0.33	0.4	0.44	0.32
Non Current Assets Total	0.82	0.95	-0.61	0.98	0.7	0.51	0.76	1.0	0.92	-0.91	0.99	0.41		0.97	0.95	0.95	0.81	0.72	0.66	0.8	0.95	0.76	0.51	0.86	0.96	0.95
Non Currrent Assets Other	0.91	0.99	-0.52	0.99	0.82	0.65	0.84	0.95	0.95	-0.88	0.98	0.5	0.97		1.0	0.99	0.9	0.84	0.73	0.89	0.99	0.77	0.58	0.9	0.99	0.86
Other Assets	0.93	0.99	-0.5	0.98	0.84	0.67	0.85	0.94	0.96	-0.88	0.98	0.49	0.95	1.0		0.99	0.92	0.87	0.75	0.9	0.99	0.78	0.58	0.91	0.99	0.83
Long Term Debt	0.93	1.0	-0.54	0.98	0.82	0.63	0.83	0.93	0.98	-0.88	0.98	0.43	0.95	0.99	0.99		0.92	0.85	0.74	0.92	1.0	0.78	0.57	0.91	1.0	0.83
Cash And Short Term Investments	1.0	0.92	-0.47	0.87	0.95	0.61	0.96	0.79	0.9	-0.73	0.87	0.52	0.81	0.9	0.92	0.92		0.88	0.68	0.99	0.92	0.74	0.59	0.92	0.91	0.62
Net Receivables	0.91	0.85	-0.26	0.83	0.83	0.83	0.79	0.7	0.84	-0.78	0.79	0.43	0.72	0.84	0.87	0.85	0.88		0.8	0.88	0.86	0.8	0.55	0.91	0.85	0.52
Common Stock Shares Outstanding	0.71	0.74	-0.21	0.73	0.52	0.66	0.54	0.64	0.72	-0.71	0.68	0.39	0.66	0.73	0.75	0.74	0.68	0.8		0.66	0.74	0.69	0.57	0.72	0.74	0.5
Short Term Investments	0.99	0.92	-0.47	0.87	0.92	0.59	0.92	0.78	0.93	-0.75	0.87	0.39	0.8	0.89	0.9	0.92	0.99	0.88	0.66		0.92	0.76	0.58	0.92	0.91	0.62
Non Current Liabilities Total	0.93	1.0	-0.53	0.98	0.82	0.64	0.83	0.94	0.98	-0.88	0.98	0.44	0.95	0.99	0.99	1.0	0.92	0.86	0.74	0.92		0.79	0.57	0.91	1.0	0.83
Inventory	0.78	0.78	-0.16	0.81	0.59	0.75	0.65	0.75	0.81	-0.93	0.76	0.22	0.76	0.77	0.78	0.78	0.74	0.8	0.69	0.76	0.79		0.62	0.93	0.79	0.72
Other Current Assets	0.61	0.57	0.22	0.54	0.56	0.57	0.61	0.5	0.55	-0.56	0.52	0.33	0.51	0.58	0.58	0.57	0.59	0.55	0.57	0.58	0.57	0.62		0.64	0.57	0.48
Other Stockholder Equity	0.94	0.91	-0.35	0.91	0.81	0.75	0.85	0.84	0.91	-0.92	0.88	0.4	0.86	0.9	0.91	0.91	0.92	0.91	0.72	0.92	0.91	0.93	0.64		0.92	0.74
Total Liab	0.92	1.0	-0.54	0.99	0.81	0.64	0.83	0.95	0.98	-0.89	0.99	0.44	0.96	0.99	0.99	1.0	0.91	0.85	0.74	0.91	1.0	0.79	0.57	0.92		0.84
Property Plant And Equipment Gross	0.64	0.83	-0.53	0.89	0.5	0.4	0.59	0.96	0.79	-0.88	0.9	0.32	0.95	0.86	0.83	0.83	0.62	0.52	0.5	0.62	0.83	0.72	0.48	0.74	0.84

Click cells to compare fundamentals

Novocure Account Relationship Matchups

Novocure fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	479.4M	1.1B	1.1B	1.2B	1.1B	651.0M
Short Long Term Debt Total	163.6M	444.2M	575.2M	584.3M	596.2M	626.1M
Other Current Liab	(1K)	35.7M	(17.8M)	(18.0M)	(16.2M)	(15.4M)
Total Current Liabilities	86.3M	113.6M	142.6M	158.8M	179.1M	188.1M
Total Stockholder Equity	217.8M	476.5M	410.5M	441.2M	362.5M	279.7M
Other Liab	11.7M	17.6M	11.2M	7.4M	8.5M	8.8M
Net Tangible Assets	217.8M	476.5M	410.5M	441.2M	507.3M	267.8M
Property Plant And Equipment Net	34.6M	41.6M	53.9M	69.0M	97.7M	102.6M
Net Debt	(13.8M)	209.5M	366.4M	468.9M	355.4M	373.2M
Retained Earnings	(650.9M)	(631.1M)	(685.9M)	(778.5M)	(985.5M)	(936.2M)
Accounts Payable	36.9M	53.6M	72.6M	85.2M	94.4M	99.1M
Cash	177.3M	234.7M	208.8M	115.3M	240.8M	164.9M
Non Current Assets Total	39.5M	52.5M	66.0M	80.1M	111.7M	117.3M
Non Currrent Assets Other	4.9M	10.9M	12.1M	11.2M	14.0M	14.7M
Other Assets	4.9M	10.9M	12.1M	11.2M	12.8M	13.5M
Long Term Debt	149.4M	429.9M	562.2M	565.5M	568.8M	597.3M
Cash And Short Term Investments	326.1M	842.6M	937.7M	969.4M	910.6M	518.3M
Net Receivables	88.1M	117.9M	110.6M	112.2M	77.1M	63.0M
Common Stock Shares Outstanding	97.2M	108.9M	103.4M	104.7M	106.4M	96.1M
Short Term Investments	148.8M	607.9M	728.9M	854.1M	669.8M	353.5M
Liabilities And Stockholders Equity	479.4M	1.1B	1.1B	1.2B	1.1B	651.0M
Non Current Liabilities Total	175.3M	461.8M	586.4M	591.7M	604.5M	634.7M
Inventory	23.7M	27.4M	24.4M	29.4M	38.2M	23.2M
Other Current Assets	1K	11.5M	807K	6.7M	8.5M	4.5M
Other Stockholder Equity	871.4M	1.1B	1.1B	1.2B	1.4B	916.6M
Total Liab	261.7M	575.5M	729.0M	750.5M	783.6M	822.8M
Total Current Assets	439.9M	999.4M	1.1B	1.1B	1.0B	607.6M
Accumulated Other Comprehensive Income	(2.8M)	(3.8M)	(3.2M)	(2.4M)	(5.5M)	(5.2M)
Property Plant Equipment	34.6M	11.4M	53.9M	32.7M	37.6M	22.9M
Retained Earnings Total Equity	(650.9M)	(631.1M)	(685.9M)	(778.5M)	(700.6M)	(735.6M)
Current Deferred Revenue	11.8M	17.8M	17.8M	18.0M	16.2M	13.4M
Long Term Debt Total	149.5M	429.9M	562.2M	565.5M	650.3M	682.9M
Capital Surpluse	871.4M	1.1B	1.1B	1.2B	1.4B	1.0B
Non Current Liabilities Other	182K	31.9M	166K	148K	18K	17.1K
Net Invested Capital	367.2M	906.4M	972.7M	1.0B	931.3M	731.9M
Net Working Capital	353.6M	885.8M	930.9M	952.8M	855.3M	696.2M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Novocure is a strong investment it is important to analyze Novocure's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Novocure's future performance. For an informed investment choice regarding Novocure Stock, refer to the following important reports:

How To Invest In Novocure

Details

Is Novocure Stock a good investment?

Details

What is Novocure's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novocure. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.

Note that the Novocure information on this page should be used as a complementary analysis to other Novocure's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for Novocure Stock analysis

When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.

	Stocks Directory Find actively traded stocks across global markets
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum

Is Novocure's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novocure. If investors know Novocure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novocure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.06)

Earnings Share

(1.81)

Revenue Per Share

4.922

Quarterly Revenue Growth

0.134

Return On Assets

(0.11)

The market value of Novocure is measured differently than its book value, which is the value of Novocure that is recorded on the company's balance sheet. Investors also form their own opinion of Novocure's value that differs from its market value or its book value, called intrinsic value, which is Novocure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novocure's market value can be influenced by many factors that don't directly affect Novocure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Novocure's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novocure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novocure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Novocure Operating Income vs Total Operating Expenses Analysis

Operating Income vs Total Operating Expenses

Operating Income vs Total Operating Expenses Correlation Analysis

Correlation Coefficient

Operating Income

Total Operating Expenses

Novocure fundamental ratios Correlations

Novocure Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Novocure fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Novocure Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Long Term Debt	+ 1.0	Short Long Term Debt Total
Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Total Liab	+ 1.0	Short Long Term Debt Total
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Other Assets	+ 1.0	Non Currrent Assets Other

Inventory	- 0.93	Retained Earnings
Retained Earnings	- 0.93	Total Current Liabilities
Other Stockholder Equity	- 0.92	Retained Earnings
Non Current Assets Total	- 0.91	Retained Earnings
Retained Earnings	- 0.9	Property Plant And Equipment Net
Total Liab	- 0.89	Retained Earnings